MENU

Alexander Kutikov Named a Young Urologist of the Year by American Urological Association

April 22, 2021

Dr. Alexander Kutikov, co-author of the studies and chief of the Division of Urology and Urologic Oncology at Fox ChaseDr. Alexander Kutikov, co-author of the studies and chief of the Division of Urology and Urologic Oncology at Fox Chase

PHILADELPHIA (April 22, 2021)—Alexander Kutikov, MD, FACS, chief of the Division of Urology and Urologic Oncology at Fox Chase Cancer Center, was recognized by the American Urological Association (AUA) as the winner of the Young Urologist of the Year Award for the Mid-Atlantic Section.

The award is presented to members of the AUA to recognize their efforts and commitment to the advancement of fellow young urologists. Kutikov was recognized by his colleagues in the AUA for his leadership and support of trainees and junior faculty.

“It is an absolute privilege to be recognized by one’s peers. Yet what’s most satisfying about this award is that the recognition highlights Fox Chase urologic oncology’s support of the next generation of urologic experts,” said Kutikov. 

“We are very fortunate here at Fox Chase to train the future leaders in the field of urology and take great pride in graduating some of the finest urologists and urologic oncologists in the world. We are immensely proud of our premier Urologic Oncology Fellowship program.” He added that he is also “tremendously grateful” to train urology residents from the Temple Health System, of which Fox Chase is a part, and the Einstein Healthcare Network.

“A recognized thought leader in urologic oncology,” the award citation stated, “Dr. Kutikov is a frequently invited speaker and panelist at national meetings on the management of bladder cancer, kidney cancer, and adrenal disorders.

Kutikov specializes in adrenal tumors, as well as prostate, bladder, kidney, penile, testicular, ureteral, and urethral cancers. His research interests include understanding the development of genitourinary cancers, determining risk factors for surgical outcomes, and optimization of treatment choices. 

In addition to serving as chief of the Division of Urology and Urologic Oncology, Kutikov is a professor in the Department of Surgical Oncology and the Roberta R. Scheller Chair in Urologic Oncology. He has been recognized as one of Philadelphia magazine’s Top Doctors for the last several years and has been listed among Castle Connolly’s Top Doctors since 2016.

“I am thankful to the AUA and my peers in the Mid-Atlantic Section for this award, and hope to continue our team’s work at Fox Chase to further the field of urologic oncology and continue to train the next generation,” said Kutikov.  

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase